Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$43.39 - $51.63 $228,795 - $272,244
5,273 New
5,273 $267,000
Q4 2022

Feb 13, 2023

BUY
$37.12 - $46.52 $949,529 - $1.19 Million
25,580 New
25,580 $966,000
Q2 2022

Aug 12, 2022

BUY
$31.71 - $43.0 $580,610 - $787,330
18,310 New
18,310 $678,000
Q1 2022

May 16, 2022

SELL
$29.88 - $37.04 $332,683 - $412,403
-11,134 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$25.61 - $35.1 $9,373 - $12,846
-366 Reduced 3.18%
11,134 $339,000
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $385,710 - $466,324
11,500 New
11,500 $386,000
Q4 2020

Feb 11, 2021

SELL
$45.3 - $60.27 $234,382 - $311,836
-5,174 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$47.45 - $62.95 $245,506 - $325,703
5,174 New
5,174 $246,000
Q2 2018

Aug 14, 2018

SELL
$40.53 - $50.7 $453,530 - $567,333
-11,190 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$44.08 - $55.05 $249,052 - $311,032
5,650 Added 101.99%
11,190 $493,000
Q4 2017

Feb 09, 2018

SELL
$50.3 - $64.39 $3,018 - $3,863
-60 Reduced 1.07%
5,540 $278,000
Q3 2017

Nov 08, 2017

SELL
$45.56 - $59.57 $86,564 - $113,183
-1,900 Reduced 25.33%
5,600 $285,000
Q2 2017

Aug 17, 2017

BUY
N/A
7,500
7,500 $381,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.